Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New series of isoniazid hydrazones linked with electron-withdrawing substituents.
Vavříková E, Polanc S, Kočevar M, Košmrlj J, Horváti K, Bosze S, Stolaříková J, Imramovský A, Vinšová J. Vavříková E, et al. Among authors: kosmrlj j. Eur J Med Chem. 2011 Dec;46(12):5902-9. doi: 10.1016/j.ejmech.2011.09.054. Epub 2011 Oct 13. Eur J Med Chem. 2011. PMID: 22018878
Biological evaluation of diazene derivatives as anti-tubercular compounds.
Cappoen D, Majce V, Uythethofken C, Urankar D, Mathys V, Kočevar M, Verschaeve L, Polanc S, Huygen K, Košmrlj J. Cappoen D, et al. Among authors: kosmrlj j. Eur J Med Chem. 2014 Mar 3;74:85-94. doi: 10.1016/j.ejmech.2013.12.057. Epub 2014 Jan 8. Eur J Med Chem. 2014. PMID: 24448419
Anti-mycobacterial activity of 1,3-diaryltriazenes.
Cappoen D, Vajs J, Uythethofken C, Virag A, Mathys V, Kočevar M, Verschaeve L, Gazvoda M, Polanc S, Huygen K, Košmrlj J. Cappoen D, et al. Among authors: kosmrlj j. Eur J Med Chem. 2014 Apr 22;77:193-203. doi: 10.1016/j.ejmech.2014.02.065. Epub 2014 Mar 1. Eur J Med Chem. 2014. PMID: 24631899
Design, synthesis and antitubercular potency of 4-hydroxyquinolin-2(1H)-ones.
de Macedo MB, Kimmel R, Urankar D, Gazvoda M, Peixoto A, Cools F, Torfs E, Verschaeve L, Lima ES, Lyčka A, Milićević D, Klásek A, Cos P, Kafka S, Košmrlj J, Cappoen D. de Macedo MB, et al. Among authors: kosmrlj j. Eur J Med Chem. 2017 Sep 29;138:491-500. doi: 10.1016/j.ejmech.2017.06.061. Epub 2017 Jun 29. Eur J Med Chem. 2017. PMID: 28689097
Diazene JK-279: potential anticancer drug.
Osmak M, Bordukalo T, Jernej B, Kosmrlj J, Polanc S. Osmak M, et al. Among authors: kosmrlj j. Anticancer Drugs. 1999 Oct;10(9):853-9. doi: 10.1097/00001813-199910000-00009. Anticancer Drugs. 1999. PMID: 10587296
Cytotoxic effects of diazenes on tumor cells in vitro.
Moskatelo D, Benjak A, Laketa V, Polanc S, Kosmrlj J, Osmak M. Moskatelo D, et al. Among authors: kosmrlj j. Chemotherapy. 2002 Mar;48(1):36-41. doi: 10.1159/000048586. Chemotherapy. 2002. PMID: 11901255
71 results